• Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products under Tilray and Aphria brands
  • Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey
  • Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Stock (TSX:TLRY) opened the day’s trading at $4.88 per share

Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands.

Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey.

“We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community,” said Blair MacNeil, President, Tilray Canada.

“Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed,” he added.

In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios.

Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products.

Under the Tilray and Aphria brands, the company released Tilray Sinaloa Gold, Tilray Sapphire Scout, Tilray Chem Cookies, and Tilray Powdered Donuts #8. And under the Aphria brands, it released Aphria Sherbet Cookies, Aphria Banana Punch, and Aphria Monkey Butter.

To further support the medical cannabis journey for patients, Tilray Medical partnered with Strainprint, a mobile app focused on medical cannabis tracking, to develop the CannaPoints
program.

Alongside advice from a physician, Tilray Medical patients can use the CannaPoints program to explore new offerings, learn more about strain details, and record the effects, making it easier for them to curate optimal personal consumption schedules, empowering them to tailor their own experiences and earn rewards through the app in the process.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.


More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.

Canopy Growth prepares for U.S. expansion with new acquisitions

Canopy Growth (TSX:WEED) exercises its options to acquire Wana and Jetty Extracts, key players in the company's U.S. expansion strategy.